Carmel, IN, United States of America

Wen Liu

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Eli Lilly and Company. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wen Liu. Retrieved from https://idiyas.com/inventor/wen-liu-jip379kp

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Wen Liu

Introduction

Wen Liu is an accomplished inventor based in Carmel, IN (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of insulin compounds. Her innovative work has led to the creation of a patent that addresses critical needs in diabetes management.

Latest Patents

Wen Liu holds a patent for "Extended Time Action Acylated Insulin Compounds." This invention represents a breakthrough in insulin delivery, providing patients with more effective management of their blood sugar levels. The patent showcases her dedication to improving healthcare outcomes for individuals with diabetes.

Career Highlights

Wen Liu is currently employed at Eli Lilly and Company, a leading global pharmaceutical company. Her role at Eli Lilly has allowed her to work on cutting-edge research and development projects that aim to enhance the quality of life for patients. With her expertise, she has become a valuable asset to her team and the company.

Collaborations

Wen Liu collaborates with her coworker, Seamus Patrick Brennan, to further advance their research initiatives. Together, they work on innovative solutions that contribute to the field of diabetes care.

Conclusion

Wen Liu's contributions to the field of pharmaceuticals, particularly through her patent on insulin compounds, highlight her role as a leading inventor. Her work at Eli Lilly and her collaborations with colleagues underscore her commitment to advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…